| Circulating microRNAs: Association with disease and potential use as biomarkers G Reid, MB Kirschner, N van Zandwijk Critical reviews in oncology/hematology 80 (2), 193-208, 2011 | 591 | 2011 |
| Haemolysis during sample preparation alters microRNA content of plasma MB Kirschner, SC Kao, JJ Edelman, NJ Armstrong, MP Vallely, ... PloS one 6 (9), e24145, 2011 | 588 | 2011 |
| The impact of hemolysis on cell-free microRNA biomarkers MB Kirschner, JJB Edelman, SCH Kao, MP Vallely, N Van Zandwijk, ... Frontiers in genetics 4, 94, 2013 | 386 | 2013 |
| Restoring expression of miR-16: a novel approach to therapy for malignant pleural mesothelioma G Reid, ME Pel, MB Kirschner, YY Cheng, N Mugridge, J Weiss, ... Annals of Oncology 24 (12), 3128-3135, 2013 | 277 | 2013 |
| Tumor suppressor microRNAs contribute to the regulation of PD-L1 expression in malignant pleural mesothelioma SC Kao, YY Cheng, M Williams, MB Kirschner, J Madore, T Lum, ... Journal of Thoracic Oncology 12 (9), 1421-1433, 2017 | 144 | 2017 |
| Increased circulating miR-625-3p: a potential biomarker for patients with malignant pleural mesothelioma MB Kirschner, YY Cheng, B Badrian, SC Kao, J Creaney, JJB Edelman, ... Journal of thoracic oncology 7 (7), 1184-1191, 2012 | 143 | 2012 |
| Combined genetic and genealogic studies uncover a large BAP1 cancer syndrome kindred tracing back nine generations to a common ancestor from the 1700s M Carbone, EG Flores, M Emi, TA Johnson, T Tsunoda, D Behner, ... PLoS genetics 11 (12), e1005633, 2015 | 107 | 2015 |
| miR-193a-3p is a potential tumor suppressor in malignant pleural mesothelioma M Williams, MB Kirschner, YY Cheng, J Hanh, J Weiss, N Mugridge, ... Oncotarget 6 (27), 23480, 2015 | 93 | 2015 |
| Fibulin-3 levels in malignant pleural mesothelioma are associated with prognosis but not diagnosis MB Kirschner, E Pulford, MA Hoda, A Rozsas, K Griggs, YY Cheng, ... British journal of cancer 113 (6), 963-969, 2015 | 80 | 2015 |
| Cell-free microRNAs: potential biomarkers in need of standardized reporting MB Kirschner, N Zandwijk, G Reid Frontiers in genetics 4, 56, 2013 | 80 | 2013 |
| MiR-score: a novel 6-microRNA signature that predicts survival outcomes in patients with malignant pleural mesothelioma MB Kirschner, YY Cheng, NJ Armstrong, RCY Lin, SC Kao, A Linton, ... Molecular oncology 9 (3), 715-726, 2015 | 75 | 2015 |
| A data-driven, knowledge-based approach to biomarker discovery: application to circulating microRNA markers of colorectal cancer prognosis F Vafaee, C Diakos, MB Kirschner, G Reid, MZ Michael, LG Horvath, ... NPJ systems biology and applications 4 (1), 20, 2018 | 56 | 2018 |
| Loss of miR-223 and JNK signaling contribute to elevated stathmin in malignant pleural mesothelioma KA Birnie, YY Yip, DCH Ng, MB Kirschner, G Reid, CM Prêle, AW Musk, ... Molecular Cancer Research 13 (7), 1106-1118, 2015 | 56 | 2015 |
| An RNAi-based screen reveals PLK1, CDK1 and NDC80 as potential therapeutic targets in malignant pleural mesothelioma A Linton, YY Cheng, K Griggs, MB Kirschner, S Gattani, S Srikaran, ... British journal of cancer 110 (2), 510-519, 2014 | 50 | 2014 |
| KCa1. 1, a calcium-activated potassium channel subunit alpha 1, is targeted by miR-17-5p and modulates cell migration in malignant pleural mesothelioma YY Cheng, CM Wright, MB Kirschner, M Williams, KH Sarun, V Sytnyk, ... Molecular cancer 15, 1-12, 2016 | 49 | 2016 |
| Dysregulated expression of the MicroRNA miR-137 and its target YBX1 contribute to the invasive characteristics of malignant pleural mesothelioma TG Johnson, K Schelch, YY Cheng, M Williams, KH Sarun, MB Kirschner, ... Journal of Thoracic Oncology 13 (2), 258-272, 2018 | 44 | 2018 |
| FGF2 and EGF induce epithelial–mesenchymal transition in malignant pleural mesothelioma cells via a MAPKinase/MMP1 signal K Schelch, C Wagner, S Hager, C Pirker, K Siess, E Lang, R Lin, ... Carcinogenesis 39 (4), 534-545, 2018 | 43 | 2018 |
| Long non coding RNAs (lncRNAs) are dysregulated in malignant pleural mesothelioma (MPM) CM Wright, MB Kirschner, YY Cheng, KJ O'Byrne, SG Gray, K Schelch, ... PLoS One 8 (8), e70940, 2013 | 37 | 2013 |
| A link between the fibroblast growth factor axis and the miR‐16 family reveals potential new treatment combinations in mesothelioma K Schelch, MB Kirschner, M Williams, YY Cheng, N van Zandwijk, ... Molecular oncology 12 (1), 58-73, 2018 | 36 | 2018 |
| ZIC1 is silenced and has tumor suppressor function in malignant pleural mesothelioma YY Cheng, MB Kirschner, NC Cheng, S Gattani, S Klebe, JJB Edelman, ... Journal of Thoracic Oncology 8 (10), 1317-1328, 2013 | 35 | 2013 |
Glen ReidThe University of Otago在 otago.ac.nz 的电子邮件经过验证
